A retrospective comparative study of prednisolone use in antagonist co-treated assisted reproductive technology cycles for patients with good prognosis

Creative Commons License

ÖZMEN B., Pabuccu E. G., ŞÜKÜR Y. E., Ulubasoglu H., Ates C., SÖNMEZER M., ...More

TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol.15, no.3, pp.147-151, 2018 (ESCI) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 3
  • Publication Date: 2018
  • Doi Number: 10.4274/tjod.12244
  • Journal Name: TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.147-151
  • Keywords: Assisted reproductive technology, glucocorticoid, gonadotropin-releasing hormone antagonist, peri-implantation period, IN-VITRO FERTILIZATION, EMBRYO TRANSFER PATIENTS, PREGNANCY RATE, RECURRENT MISCARRIAGE, SPERM INJECTION, IMPLANTATION, PLACEBO, IMMUNOSUPPRESSION, IMPROVEMENT, FAILURE
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

Objective: To investigate the impact of peri-implantation prednisolone use and its duration in antagonist co-treated assisted reproductive technology (ART) cycles of patients with good prognosis.